HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective actions of naloxone in hemorrhagic shock.

Abstract
The opiate antagonist, naloxone, was infused at 8 mg x kg-1 x h-1 in cats to determine its effect in hemorrhagic shock. Hemorrhaged cats treated with naloxone maintained postreinfusion mean arterial blood pressure at a higher value compared to those receiving only the vehicle. Final pressures were 77 +/- 9 mmHg for cats receiving vehicle compared to 120 +/- 6 mmHg for cats receiving naloxone. These values represent 58 +/-7 and 98 +/- 6% of initial pressures for vehicle- and naloxone-treated cats, respectively (P < 0.001). Naloxone also moderated increases in circulating lysosomal hydrolase activity (4- vs. 23-fold increase) and total plasma proteolysis (33 vs. 100% increase). Plasma myocardial depressant factor activity was also significantly reduced in naloxone-treated hemorrhaged cats compared to shock cats given 0.9% NaCl (16 +/- 3 vs. 58 +/- 4 U, respectively; P < 0.001). Studies on cat papillary muscles demonstrated that naloxone at concentrations slightly higher than estimated plasma values during shock exerted a moderate positive inotropic effect. Our results show that naloxone improved the hemodynamic and biochemical state of cats in hemorrhagic shock. Inhibition of proteolysis and stabilization of lysosomal membranes appear to be ivolved in the protective action of naloxone, along with the well-known opiate-antagonistic action of this agent.
AuthorsM T Curtis, A M Lefer
JournalThe American journal of physiology (Am J Physiol) Vol. 239 Issue 3 Pg. H416-21 (Sep 1980) ISSN: 0002-9513 [Print] United States
PMID7435587 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Myocardial Depressant Factor
  • Naloxone
Topics
  • Animals
  • Blood Pressure
  • Cats
  • Dose-Response Relationship, Drug
  • Liver (metabolism)
  • Myocardial Depressant Factor (biosynthesis)
  • Naloxone (pharmacology, therapeutic use)
  • Pancreas (metabolism)
  • Papillary Muscles (metabolism)
  • Peptide Biosynthesis
  • Shock, Hemorrhagic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: